These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23922014)

  • 1. Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent.
    Jiang SN; Park SH; Lee HJ; Zheng JH; Kim HS; Bom HS; Hong Y; Szardenings M; Shin MG; Kim SC; Ntziachristos V; Choy HE; Min JJ
    Mol Ther; 2013 Nov; 21(11):1985-95. PubMed ID: 23922014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer.
    Nguyen VH; Kim HS; Ha JM; Hong Y; Choy HE; Min JJ
    Cancer Res; 2010 Jan; 70(1):18-23. PubMed ID: 20028866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted deletion of the ara operon of Salmonella typhimurium enhances L-arabinose accumulation and drives PBAD-promoted expression of anti-cancer toxins and imaging agents.
    Hong H; Lim D; Kim GJ; Park SH; Sik Kim H; Hong Y; Choy HE; Min JJ
    Cell Cycle; 2014; 13(19):3112-20. PubMed ID: 25486570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visualization of Anticancer Salmonella typhimurium Engineered for Remote Control of Therapeutic Proteins.
    Nguyen VH; Min JJ
    Methods Mol Biol; 2016; 1409():135-42. PubMed ID: 26846808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming a Doxycycline-Inducible Gene Switch System for Bacteria-Mediated Cancer Therapy.
    Ngo HT; Nguyen DH; You SH; Van Nguyen K; Kim SY; Hong Y; Min JJ
    Mol Imaging Biol; 2024 Feb; 26(1):148-161. PubMed ID: 38017353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium.
    Hayashi K; Zhao M; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Hoffman RM
    J Cell Biochem; 2009 Apr; 106(6):992-8. PubMed ID: 19199339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.
    Flentie K; Kocher B; Gammon ST; Novack DV; McKinney JS; Piwnica-Worms D
    Cancer Discov; 2012 Jul; 2(7):624-37. PubMed ID: 22728436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo.
    Loessner H; Endmann A; Leschner S; Westphal K; Rohde M; Miloud T; Hämmerling G; Neuhaus K; Weiss S
    Cell Microbiol; 2007 Jun; 9(6):1529-37. PubMed ID: 17298393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic screening of anaerobically regulated promoters from Salmonella and its antitumor applications.
    Chen J; Wei D; Zhuang H; Qiao Y; Tang B; Zhang X; Wei J; Fang S; Chen G; Du P; Huang X; Jiang W; Hu Q; Hua ZC
    Mol Cell Proteomics; 2011 Jun; 10(6):M111.009399. PubMed ID: 21474796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment.
    Yoon W; Yoo Y; Chae YS; Kee SH; Kim BM
    Ann Oncol; 2018 Sep; 29(9):2010-2017. PubMed ID: 30016386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
    Hoffman RM
    Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic.
    Leschner S; Deyneko IV; Lienenklaus S; Wolf K; Bloecker H; Bumann D; Loessner H; Weiss S
    Nucleic Acids Res; 2012 Apr; 40(7):2984-94. PubMed ID: 22140114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral cytokine gene therapy against murine tumor using attenuated Salmonella typhimurium.
    Yuhua L; Kunyuan G; Hui C; Yongmei X; Chaoyang S; Xun T; Daming R
    Int J Cancer; 2001 Nov; 94(3):438-43. PubMed ID: 11745427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models.
    Liang K; Liu Q; Li P; Han Y; Bian X; Tang Y; Kong Q
    Cancer Gene Ther; 2018 Aug; 25(7-8):167-183. PubMed ID: 29755110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth.
    Loeffler M; Le'Negrate G; Krajewska M; Reed JC
    Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12879-83. PubMed ID: 17652173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-specific delivery of histidine-rich glycoprotein suppresses tumor growth and metastasis by anti-angiogenesis and vessel normalization.
    Cheng X; Zhang X; Cheng W; Chen J; Ma C; Yang B; Hua ZC
    Curr Gene Ther; 2014; 14(2):75-85. PubMed ID: 24606115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized Doxycycline-Inducible Gene Expression System for Genetic Programming of Tumor-Targeting Bacteria.
    Nguyen DH; You SH; Vo AN; Ngo HT; Van Nguyen K; Duong MT; Choy HE; Song M; Hong Y; Min JJ
    Mol Imaging Biol; 2022 Feb; 24(1):82-92. PubMed ID: 34403085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AI-2 quorum sensing controlled delivery of cytolysin-A by tryptophan auxotrophic low-endotoxic Salmonella and its anticancer effects in CT26 mice with colon cancer.
    Aganja RP; Sivasankar C; Lee JH
    J Adv Res; 2024 Jul; 61():83-100. PubMed ID: 37689243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for Tumor Targeting with Salmonella typhimurium A1-R.
    Hoffman RM; Zhao M
    Methods Mol Biol; 2016; 1409():143-64. PubMed ID: 26846809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined prokaryotic-eukaryotic delivery and expression of therapeutic factors through a primed autocatalytic positive-feedback loop.
    Shi L; Yu B; Cai CH; Huang W; Zheng BJ; Smith DK; Huang JD
    J Control Release; 2016 Jan; 222():130-40. PubMed ID: 26682504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.